This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silva, R. A.
Right arrow Articles by Appelberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silva, R. A.
Right arrow Articles by Appelberg, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2001, p. 1312-1314, Vol. 45, No. 4
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.4.1312-1314.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Blocking the Receptor for Interleukin 10 Protects Mice from Lethal Listeriosis

Regina A. Silva and Rui Appelberg*

Laboratory of Microbiology and Immunology of Infection, Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal

Received 27 September 2000/Returned for modification 13 December 2000/Accepted 12 January 2001

High doses of Listeria monocytogenes overcome the ability of a normal mouse to control the infection, due to massive bacterial replication. Treatment with an anti-interleukin 10 (IL-10) receptor monoclonal antibody prevented the fatal course of infection with high doses of bacteria. This work shows that blocking the receptor for IL-10 may have useful therapeutic applications.

* Corresponding author. Mailing address: Laboratory of Microbiology and Immunology of Infection, Institute for Molecular and Cell Biology, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Phone: 351.226074952. Fax: 351.226099157. E-mail: rappelb{at}ibmc.up.pt.

Antimicrobial Agents and Chemotherapy, April 2001, p. 1312-1314, Vol. 45, No. 4
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.4.1312-1314.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Roque, S., Nobrega, C., Appelberg, R., Correia-Neves, M. (2007). IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy. J. Immunol. 178: 8028-8035 [Abstract] [Full Text]  
  • Foulds, K. E., Rotte, M. J., Seder, R. A. (2006). IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection. J. Immunol. 177: 2565-2574 [Abstract] [Full Text]  
  • Scheckelhoff, M., Deepe, G. S. Jr. (2005). A Deficiency in Gamma Interferon or Interleukin-10 Modulates T-Cell-Dependent Responses to Heat Shock Protein 60 from Histoplasma capsulatum. Infect. Immun. 73: 2129-2134 [Abstract] [Full Text]  
  • Mathers, A. R., Cuff, C. F. (2004). Role of Interleukin-4 (IL-4) and IL-10 in Serum Immunoglobulin G Antibody Responses following Mucosal or Systemic Reovirus Infection. J. Virol. 78: 3352-3360 [Abstract] [Full Text]  
  • Deepe, G. S. Jr., Gibbons, R. S. (2003). Protective and Memory Immunity to Histoplasma capsulatum in the Absence of IL-10. J. Immunol. 171: 5353-5362 [Abstract] [Full Text]  
  • Aliberti, J., Serhan, C., Sher, A. (2002). Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection. JEM 196: 1253-1262 [Abstract] [Full Text]  
  • Silva, R. A., Pais, T. F., Appelberg, R. (2001). Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination. J. Immunol. 167: 1535-1541 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»